1h Free Analyst Time
The synthetic biology market is forecasted to grow by USD 44.01 billion during 2024-2029, accelerating at a CAGR of 25.7% during the forecast period. The report on the synthetic biology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing applications leading to growing adoption of synthetic biology, growing investments in synthetic biology processes and techniques, and increasing demand for synthetic genes and synthetic cells.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The synthetic biology market is segmented as below:
By Application
- Healthcare
- Industrial
- Food and agriculture
- Others
By Product
- Oligonucleotides
- Enzymes
- Cloning technology kits
- Xeno-nucleic acids
- Chassis organism
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the synthetic biology market covers the following areas:
- Synthetic Biology Market sizing
- Synthetic Biology Market forecast
- Synthetic Biology Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Application
9 Market Segmentation by Product
10 Customer Landscape
11 Geographic Landscape
12 Drivers, Challenges, and Opportunity/Restraints
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global synthetic biology market: Agilent Technologies Inc., Amyris Inc., Arzeda Corporation, Bolt Threads, Codexis Inc, Conagen Inc., Creative Biogene, DNA Script, Ecovative Design LLC, Genomatica Inc., Ginkgo Bioworks Holdings Inc., Huue, Inc., Integrated DNA Technologies Inc., Joyn Bio LLC, LanzaTech Global Inc., Mammoth Biosciences, Inc., Merck KGaA, Novozymes AS, Thermo Fisher Scientific Inc., and Twist Bioscience Corp..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is evolving regulatory framework around synthetic biology."
According to the report, one of the major drivers for this market is the growing applications leading to growing adoption of synthetic biology.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Agilent Technologies Inc.
- Amyris Inc.
- Arzeda Corporation
- Bolt Threads
- Codexis Inc
- Conagen Inc.
- Creative Biogene
- DNA Script
- Ecovative Design LLC
- Genomatica Inc.
- Ginkgo Bioworks Holdings Inc.
- Huue INC.
- Integrated DNA Technologies Inc.
- Joyn Bio LLC
- LanzaTech Global Inc.
- Mammoth Biosciences INC.
- Merck KGaA
- Novozymes AS
- Thermo Fisher Scientific Inc.
- Twist Bioscience Corp.
